Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro. - Wikidata - thesis-toulmin - TriplyDB

Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.

Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.

http://www.wikidata.org/entity/Q41952109

about

Colitis affects the smooth muscle and neural response to motilin in the rabbit antrum Ghrelin and motilin receptor agonists: time to introduce bias into drug design.The investigational drug camicinal for the treatment of gastroparesis.The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.The hungry stomach: physiology, disease, and drug development opportunities.Translational neuropharmacology: the use of human isolated gastrointestinal tissues.Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists.Development of drugs for gastrointestinal motor disorders: translating science to clinical need.Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists.Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.Ghrelin and Motilin Control Systems in GI Physiology and Therapeutics.Effect of TZP-201, a novel motilin receptor antagonist, in the colon of the musk shrew (Suncus murinus).

P2860

Q33673105-A9A09F59-7859-4A69-B0E6-729CE7C5ECD4 Q34398651-184003F3-1C5F-45BA-B908-4280DA4C70A5 Q34444648-CE276F73-2BD0-4212-9EDD-4BFF4557CD39 Q34645793-81BAA521-04F0-4EDC-9EDE-20AA148D5B58 Q35215647-3C2356F0-130E-4544-83B9-F4842721FAED Q36603175-C9730029-72F7-4D1D-841B-CEE28F6C9FB7 Q36619744-8A00580B-93EA-4765-AC48-EF28A591A376 Q37079261-D772D795-12B4-4B78-83FC-747215877A1E Q37337819-ADDE2894-3BB6-4228-9964-CD112FC9FD80 Q38590705-20179971-A901-4987-B200-AC04B6191464 Q43358150-5D48944B-FDBB-41BC-B361-8F898395023C Q46119494-AE2F1EE8-ED76-4005-845D-0EB56F42A96F

P2860

Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.

http://www.wikidata.org/entity/Q41952109

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Differences between the abilit ...... ate gastric motility in vitro.

@en

type

label

Differences between the abilit ...... ate gastric motility in vitro.

@en

prefLabel

Differences between the abilit ...... ate gastric motility in vitro.

@en

P1433

Q41952109-7E2F3C0B-DD66-4BD6-9180-5BAA6ACA46A7

P1476

Q41952109-BBB7C8F6-2E42-4401-B3B0-0009E97C76B4

P2093

Q41952109-1DC1748E-32C6-4FD6-878D-75F9FBC3CF13

Q41952109-205FC6AC-D76D-458D-B124-78B3D015A8C2

Q41952109-BDEE2E27-2931-4EFE-978A-B1FBFE19BF5C

Q41952109-EEEE8CF4-FCC9-4634-9EB6-E9D65F25A70B

P2860

Q41952109-04B36193-DCF6-42CD-90F4-51A882A22613

Q41952109-0AB8FEDE-C95B-452F-A531-3D1217E67B92

Q41952109-1166276A-9B2E-45E1-B27C-97C0DBF8A689

Q41952109-2FD13120-CC09-4A60-92A2-3E1E97F509FF

Q41952109-3252E45B-7ED0-45A9-BE57-24D94C2567A5

Q41952109-33418694-9409-4550-A32E-DCFE98C62960

Q41952109-396A4496-1A4C-4008-B817-6093C7991DC5

Q41952109-42914478-7907-48CD-BBFC-956119425F85

Q41952109-4DBA8448-DFF2-4EA9-9A1B-2FA9D53BE566

Q41952109-57CB48ED-5D35-48A9-83B9-E9FC6D059F57

P304

Q41952109-4F7DBE2A-07D1-444D-8011-CB4E12BDE8BF

P31

Q41952109-B3392D13-9720-4E9B-818E-CE3A0D6FBA4D

P356

Q41952109-7DAAC59B-3AC8-4257-BF03-111458651D7A

P407

Q41952109-D3A61DAC-4C34-4A96-B876-7B295F40EDB6

P433

Q41952109-321C8DEF-BBFA-4F81-8CEB-75DA74529B5F

P478

Q41952109-3A0D516B-A9EB-4890-8125-9EF20E10A66A

P50

Q41952109-BC632897-27F8-474F-99AF-025B5A78E459

P577

Q41952109-FAC43DA2-1C3F-4E0D-90B5-4C750A0132C2

P5875

Q41952109-1147CA89-3F30-4632-A580-16E65E53049E

P698

Q41952109-25256297-5129-4FF5-AFBF-1C4FE2D6B163

P932

Q41952109-1CCABFDD-3921-4C27-A2D3-A229A45C9ABD

P356

P1433

British Journal of Pharmacology

P1476

Differences between the abilit ...... late gastric motility in vitro

@en

P2093

A Bassil

http://www.w3.org/2001/XMLSchema#string

E M Jarvie

http://www.w3.org/2001/XMLSchema#string

S Corcoran

http://www.w3.org/2001/XMLSchema#string

V J North Laidler

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor for motilin identified in the human gastrointestinal system

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum

The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.

Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience.

Pharmacotherapy of gastroparesis.

5-HT4 receptor ligands: applications and new prospects.

Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis.

Characterization of agonist-induced motilin receptor trafficking and its implications for tachyphylaxis.

P304

455-462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0707118

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

150

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6590803

http://www.w3.org/2001/XMLSchema#string

P698

17211452

http://www.w3.org/2001/XMLSchema#string

P932

2189716

http://www.w3.org/2001/XMLSchema#string